Open original FDA record ↗Recall record
- FDA identifier
- Z-1065-2011
- Company in FDA record
- Leica Microsystems, Inc.
- FDA classification date
- Feb 9, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Users of the Bond Polymer Refine Detection System, DS9800, may experience instances of "weak staining" due to the DAB Part B component, which may give a false negative result.
Source facts
- Action
- Leica Microsystems sent Medical Device Field Correction letters dated 11/16/10 to the affected users of the Bond Polymer Refine Detection System, DS9800 via first class mail on the same date, informing them that they may experience instances of "weak staining" due to the DAB Part B component in the affected lots, which may give a false negative result. The users were requested to test their DS9800 System prior to use to rule out that the DAB Part B components have been affected, using the enclosed testing protocol. If their system is affected, the users were instructed not to use it and contact Leica Technical Assistance Center for a replacement. The accounts were asked to complete the attached Acknowledgement Form, acknowledging the receipt and understanding of the letter, listing the lot numbers of the units at their facility and fax it back to Leica at 1-847-607-3147. Additional questions should be addressed to the firm's office of Regulatory Affairs and Quality Assurance.
- Initiated
- 2010-11-16
- Root cause
- Other
- Terminated
- 2011-10-17
- Distribution
- Worldwide Distribution -- USA and Canada.
- Recall number
- Z-1065-2011
- Recall status
- Terminated
- CDRH record ID
- 95889
- FDA classified
- 2011-02-09
- Recall event number
- 57333